Create a free Manufacturing.net account to continue

Honeywell Completes Acquisition of Sigma-Aldrich's Research Chemical Business

The acquisition will broaden Honeywell’s offerings for higher purity solutions used in drug research, medical diagnostic testing and other laboratory applications.

Mnet 33652 Honeywell

Honeywell has completed the acquisition of the Seelze, a German laboratory research chemicals business, from Sigma-Aldrich. The acquisition will broaden Honeywell’s offerings for higher purity solutions used in drug research, medical diagnostic testing and other laboratory applications.

The acquisition includes the Fluka-branded solvents and inorganic chemistry portfolio and the Sigma-Aldrich-branded solvents and inorganic chemistry portfolio in the European Economic Area (EEA). Those offerings are now part of Honeywell’s broader portfolio of offerings for research chemicals, which already includes the Riedel-de Haën® and Burdick & Jackson® brands.

The Honeywell portfolio now includes six product lines:

  • Fluka® chemicals and reagents used for biochemical research and other chemical and pharmaceutical applications.
  • Hydranal®  Karl Fischer titration reagents used by laboratories to measure moisture content in liquids and solids.
  • Chromasolv® high-purity solvents for chromatography, a technique used to separate and analyze complex mixtures.
  • Riedel-de HaĂ«n® high-quality research chemicals used in pharmaceutical production and bioscience.
  • Burdick & Jackson® high-purity solvents, reagents and chromatography products for laboratories and pharmaceutical production.
  • Sigma-Aldrich® solvents and inorganics sold into the European Economic Area.

The acquired business employs approximately 200 people, primarily in Seelze, with sales and marketing personnel throughout Europe. Honeywell’s Seelze plant, which manufactures Riedel-de Haën-branded products, currently makes the majority of the products in the acquired business.

The acquired business will be integrated into Honeywell’s Fine Chemicals business and will continue to be led by the core leadership team of the acquired company. With two production sites, Seelze and Muskegon, Michigan, the combined business unit will be able to develop and manufacture high-purity research chemicals and other materials used in new drug discovery, medical diagnostic testing and other laboratory applications.